Jpmorgan Chase & CO Edap Tms Sa Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Edap Tms Sa stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5 shares of EDAP stock, worth $13. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 29,671
99.98%
Holding current value
$13
Previous $218,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EDAP
# of Institutions
42Shares Held
15.9MCall Options Held
60.5KPut Options Held
158K-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$19.6 Million4.02% of portfolio
-
Morgan Stanley New York, NY3.37MShares$9.07 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD1.48MShares$3.97 Million0.25% of portfolio
-
Archon Capital Management LLC Seattle, WA1.14MShares$3.05 Million5.09% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA809KShares$2.18 Million0.01% of portfolio
About EDAP TMS SA
- Ticker EDAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,145,300
- Market Cap $97.2M
- Description
- EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...